Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-042134
Filing Date
2025-03-19
Accepted
2025-03-19 17:01:13
Documents
2
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1521
2 EX-24 siga-ex24.htm EX-24 9126
  Complete submission text file 0000950170-25-042134.txt   12139
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Issuer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O METLIFE INC ONE MADISON AVE NEW YORK NY 10010
Business Address
KEANE JOHN M (Reporting) CIK: 0001267719 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38436 | Film No.: 25753566